August 2021 FDA Recall Drug by Akorn, Inc.
D-0802-2021 - Failed impurities/degradation specification

This Class II drug recall was voluntarily initiated by Akorn, Inc. on August 13, 2021 for the product Drug. The FDA reported the reason for recall as failed impurities/degradation specification. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0802-2021

Reason for Recall
Failed impurities/degradation specification: Out of Specification for an unknown impurity observed in topical product.
Initiated
08-13-2021
Reported
09-22-2021
Quantity
264 bottles; 48 bottles lot 372286 and 216 bottles lot 372289

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Betamethasone Dipropionate Lotion USP (Augmented), 0.05%, packaged in a) 30 mL bottle (NDC 61748-480-30), b) 60 mL bottle (NDC 61748-480-60), Rx only, Manufactured by: Hi-Tech Pharmacal Co. Inc., Amityville,NY 11701

Batch or Lot Expiration Information

Lot# : a) 372286, 372289, Exp 1/31/2022, b) 372286, 372289, Exp 1/31/2022